Boston Millennia Partners

Contact Us | Site Map | Search


	Our Firm

	Our Team

	Our Portfolio

	Resources

	News



			Dana Callow Managing General Partner Read It >



			Jean-Yves Lagarde Partner



	Mike Koziel from Athenix on Boston Millennia Partners...




	Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.

PAREXEL Named as One of the Top 10 Publicly Traded Companies Based in Massachusetts The Boston Globe, the premier daily newspaper in the Boston area where PAREXEL’s headquarters office is located, recently ranked PAREXEL # 10 in its list of the region’s top 100 businesses. Learn More >
	Next >

CombinatoRx Reports Positive Phase 2 Trial Results for CRx-401 CombinatoRx reported positive results for its Phase 2 clinical study of CRx-401 as an add-on to metformin therapy in Type 2 diabetes which demonstrated that CRx-401 performed statistically significantly better than bezafibrate on the primary efficacy endpoint. Learn More >
< Previous	Next >

Dartmouth-Hitchcock Medical Center Selects MedAptus for Charge Capture Deployment Dartmouth-Hitchcock Clinic will be broadening its deployment of the MedAptus Professional offering, Practice Plus Edition. Learn More >
< Previous	Next >

University of Minnesota Physicians Chooses MedAptus Following Comprehensive Vendor Review MedAptus today announced that University of Minnesota Physicians (UMP), a premier multi-specialty physician organization, has selected MedAptus’ Practice Plus Edition for charge capture automation. Learn More >
< Previous	Next >

MedAptus’ Charge Capture Technology Deployed at Leading Manhattan Cardiovascular Practice MedAptus announced that the distinguished Lenox Hill Interventional Cardiac & Vascular Services, PC (LHICVS) is the latest cardiology group to implement Professional Intelligent Charge Capture. Learn More >
< Previous	Next >

CombinatoRx Announces Oncology Collaboration with Novartis CombinatoRx announced a strategic alliance with Novartis focused on the discovery of novel anti-cancer combinations. Learn More >
< Previous	Next >

MedAptus Expands Board of Directors MedAptus announced the addition of two new, independent directors, Linda Beneze and Laurence J. Hagerty, to its Board of Directors. Learn More >
< Previous	Next >

EPIX Pharmaceuticals Commences Exchange Offer for $100 Million Convertible Notes EPIX announced that it has commenced an exchange offer for all of its $100 million aggregate principal amount of 3.00% Convertible Senior Notes due 2024 (the "Exchange Offer"). Learn More >
< Previous	Next >

PHT Corporation Names Finance Industry Senior Executive John J. Arcari as CFO PHT Corporation announced that John J. Arcari, CPA, MBA, joined the company as Chief Financial Officer, reporting directly to PHT President and CEO Phil Lee. Learn More >
< Previous	Next >

MedAptus Secures $6 Million Investment MedAptus announced that it has secured $6 million in capital in a financing led by existing investor, Boston Millennia Partners. This investment will enable MedAptus to further support the growth of its Intelligent Charge Capture suite of products. Learn More >
< Previous

Click Here to receive news updates
from Boston Millennia Partners >

	Video: Large \| Small
	Video: Large \| Small


			Healthcare information is becoming broadly available to consumers, which is expanding basic demand. Learn More >

			Three key areas of opportunity in the Life Sciences sector are drug discovery & development... Learn More >

|

Our Firm Our Team Our Portfolio Resources News

© 2008 Boston Millennia Partners All Rights Reserved

BMP Extranet »